Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP89 | DOI: 10.1530/endoabs.110.EP89

1Sant’Andrea University Hospital, Rome, Italy; 2Sapienza University of Rome, Rome, Italy


JOINT1452

The diagnosis of Cushing’s syndrome is based on the inhibition test with 1 mg dexamethasone (1 mg DST), 24-h urine free cortisol, and serum and salivary cortisol measurements at midnight. Nevertheless, the diagnosis is challenging and often fraught with many pitfalls depending on several factors, such as taking drugs that interfere with the hypothalamic-pituitary-adrenal axis (HPA axis), the presence of molecules active on CYP3A4 enzyme and many other factors such as age, sex, and body mass index. In addition, some diseases such as renal and liver failure, or psychiatric disorders, reduce the diagnostic power of the tests commonly used in the diagnosis of hypercortisolism. We propose a new diagnostic strategy, simple to perform, easy to reproduce and with a high diagnostic performance. It consists of measurements of salivary cortisol by LC-MS/MS method, at three different times of the day: the first in the morning (0800 h), the second around 1400 h and the third between 2300 h and 2400 h. The reproducibility and specificity of the test identify patients with hypercortisolism in 95% of cases at midnight. Interestingly, when considering two specific points on the salivary cortisol curve, the success rate rises to 100%. Furthermore, the method allows diagnosis even in patients who cannot perform the commonly used diagnostic tests.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches